Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19

Aim. To evaluate the changes of the N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration in patients with sinus tachycardia after coronavirus disease 2019 (COVID-19) during ivabradine monotherapy or in combination with β-blockers (BBs) compared to BB monotherapy.Material and methods. T...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, T. S. Vargina, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2023-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	novel coronavirus infection covid-19 post-covid tachycardia sinus tachycardia ivabradine nt-probnp natriuretic peptide sinoatrial cell if channel blocker
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01)

Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience
by: V. I. Podzolkov, et al.
Published: (2021-05-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy
by: Yu. A. Bunin, et al.
Published: (2019-03-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

Tachycardia induced cardiomyopathy due to ectopic atrial tachycardia originating from the atrial appendage: A case series and review of literature
by: Abhinav Aggarwal, et al.
Published: (2025-03-01)

Modern treatment of supraventricular tachycardia
by: A. I. Tarzimanova, et al.
Published: (2020-11-01)

NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01)

Use of ivabradine in children with junctional ectopic tachycardia after pediatric cardiac surgery; two‐centre experience
by: Hacer Kamali, et al.
Published: (2024-12-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)

Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels
by: Ruxandra Maria Christodorescu, et al.
Published: (2024-11-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis
by: V. I. Podzolkov, et al.
Published: (2022-01-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
by: Yuancheng Zhao, et al.
Published: (2023-12-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure
by: Victor José Leal-Alcántara, et al.
Published: (2025-06-01)

Navigating the challenges of NT-proBNP result disclosure in clinical research
by: Denise A. Kent, et al.
Published: (2025-01-01)

Prevalence of periodontitis in chronic heart failure patients and its relationship with NT-ProBNP: A cross-sectional study
by: Sonika Sharma, et al.
Published: (2025-03-01)

Prognostic significance of the biomarker NT-proBNP in the surgical treatment of aortic stenosis (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-06-01)

Assessment of the Level of NT-proBNP in Patients with Arterial Hypertension Aged 80 Years and Older, Depending on the Presence of Heart Failure and Senile Asthenia Syndrome
by: V A. Safronenko, et al.
Published: (2024-10-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis
by: Noelia Costa-Rodríguez, et al.
Published: (2025-07-01)

EVALUATION OF CORRELATION BETWEEN NT-proBNP BIOMARKER WITH RATES OF HEMODYNAMICS AND PULMONARY EXTRAVASCULAR WATER IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
by: S. A. Komarov, et al.
Published: (2017-11-01)

Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study [Corrigendum]
by: Liu R, et al.
Published: (2025-03-01)

Relationship between Mildly Elevated NT-proBNP Levels and Heart Failure Stages in the Elderly
by: Rana A. Hallak, et al.
Published: (2024-10-01)

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease
by: Jianping Liu, et al.
Published: (2025-04-01)

Changes in sST2 and NT-proBNP levels predict early cardiac arrhythmia in breast cancer patients treated with anthracycline-containing chemotherapies
by: Cuncun Chen, et al.
Published: (2024-12-01)

NT-proBNP in Acute De Novo Heart Failure: A Key Biomarker for Predicting Myocardial Recovery—COMFE Registry
by: Raquel López-Vilella, et al.
Published: (2025-03-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Role of NT-proBNP and Myeloperoxidase as Predictors of Abnormal Stress Test Results and Revascularization in Intermediate-Risk NSTE-ACS: A Prospective Study
by: Enrique Soltero-Mariscal, et al.
Published: (2025-02-01)